Gianluigi Forloni

Research.com Recognitions

• 2023 - Research.com Biology and Biochemistry in Italy Leader Award
• 2004 - Member of the European Academy of Sciences

Overview

Best Publications

• Neurotoxicity of a prion protein fragment

  Gianluigi Forloni;Nadia Angeretti;Roberto Chiesa;Enrico Monzani

  1164
  Citations

• Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

  Claudia Balducci;Marten Beeg;Matteo Stravalaci;Antonio Bastone

  574
  Citations

• Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia

  Pierluigi Quadri;Claudia Fragiacomo;Rita Pezzati;Enrica Zanda

  459
  Citations

• Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

  Roberta Borghi;Roberta Marchese;Alessandro Negro;Lucio Marinelli

  459
  Citations

• Frontotemporal dementia and its subtypes: a genome-wide association study

  Raffaele Ferrari;Raffaele Ferrari;Dena G Hernandez;Dena G Hernandez;Michael A Nalls;Jonathan D Rohrer

  433
  Citations

• Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35

  Gianluigi Forloni;Roberto Chiesa;Simona Smiroldo;Laura Verga

  428
  Citations

• Sporadic human prion diseases: molecular insights and diagnosis

  Gianfranco Puoti;Alberto Bizzi;Gianluigi Forloni;Jiri G Safar

  415
  Citations

• Long-term acetyl-L-carnitine Treatment in Alzheimer's Disease

  A. Spagnoli;U. Lucca;G. Menasce;L. Bandera

  348
  Citations

• Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

  Gianluigi Forloni;Federica Demicheli;Sussana Giorgi;Caterina Bendotti

  320
  Citations

• Anti-amyloidogenic activity of tetracyclines: studies in vitro

  Gianluigi Forloni;Laura Colombo;Laura Girola;Fabrizio Tagliavini

  307
  Citations

• Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro

  Fabrizio Tagliavini;Frances Prelli;Laura Verga;Giorgio Giaccone

  298
  Citations

• The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by α-synuclein or amyloid-β (1-42) peptide

  Diego Albani;Letizia Polito;Sara Batelli;Stefania De Mauro

  282
  Citations

• JNK Signalling: A Possible Target to Prevent Neurodegeneration

  Tiziana Borsello;Gianluigi Forloni

  279
  Citations

• Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

  Roberto Del Bo;Nadia Angeretti;Elisa Lucca;Maria Grazia De Simoni

  272
  Citations

• TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers

  N. Finch;M. M. Carrasquillo;M. Baker;N. J. Rutherford

  256
  Citations

• Evaluation of Quinacrine Treatment for Prion Diseases

  A. Barret;F. Tagliavini;G. Forloni;C. Bate

  246
  Citations

• Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion Protein

  C. Selvaggini;L. De Gioia;L. Cantù;Elena Maria Ghibaudi

  240
  Citations

• Tetracyclines affect prion infectivity

  Gianluigi Forloni;Selina Iussich;Tazeen Awan;Laura Colombo

  233
  Citations

• Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.

  F. Tagliavini;R. A. Mcarthur;B. Canciani;G. Giaccone

  233
  Citations

• Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.

  L De Gioia;C Selvaggini;E Ghibaudi;L Diomede

  228
  Citations